Financials
- Market Capitalization 45.2 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.werewolftx.com
- Headquarter Delaware, United States
- FIGI BBG00QXQ9XK4
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.49
Rapporto prezzo/fatturato
-5.21
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4285 | VERU Veru Inc. - Common Stock | 2.80 USD | +6.46% | +8.53% | +20.69% | +17.15% | 47.74 M USD | ||
| 4299 | TCRX TScan Therapeutics, Inc. - Common Stock | 0.73 USD | -2.67% | -6.41% | -3.95% | -59.44% | 46.36 M USD | ||
| 4306 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 2.01 USD | +7.49% | +6.91% | +3.61% | -79.15% | 45.59 M USD | ||
| 4309 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.14 USD | +0.94% | -1.38% | +0.47% | -46.23% | 45.02 M USD |